OpenAI acquires biotech startup Orchestra Bio

Signals OpenAI moving deeper into life sciences and drug development verticals.

OpenAI acquired Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development.

Read it at OpenAI →

Coverage: 29 sources, in order

1. 20 Oct 00:00 OpenAI Read the article →
2. 20 Oct 17:55 Axios Read the article →
3. 20 Oct 17:55 Yahoo Finance Read the article →
4. 20 Oct 17:58 Axios Read the article →
5. 20 Oct 18:03 OpenAI Read the article →
6. 20 Oct 18:07 Investing.com Read the article →
7. 20 Oct 18:23 RuntimeWire Read the article →
8. 20 Oct 18:27 TradingView Read the article →
9. 20 Oct 18:27 Seeking Alpha Read the article →
10. 20 Oct 18:35 Yahoo Finance Read the article →
11. 20 Oct 18:49 Yahoo Finance Read the article →
12. 20 Oct 18:56 Dealroom Read the article →
13. 20 Oct 19:07 GuruFocus Read the article →
14. 20 Oct 19:28 PharmTech.com Read the article →
15. 20 Oct 19:54 The Information Read the article →
16. 20 Oct 20:04 Interesting Engineering Read the article →
17. 20 Oct 20:04 citybiz Read the article →
18. 20 Oct 20:09 Benzinga Read the article →
19. 20 Oct 20:09 Benzinga Read the article →
20. 20 Oct 20:35 TechCrunch Read the article →
21. 20 Oct 20:35 TechCrunch Read the article →
22. 20 Oct 20:35 Yahoo Finance Read the article →
23. 20 Oct 20:51 Pluang Read the article →
24. 20 Oct 20:53 Unite.AI Read the article →
25. 20 Oct 21:46 Decrypt Read the article →
26. 20 Oct 21:46 Yahoo Finance Read the article →
27. 20 Oct 22:56 TodayPress.tv Read the article →
28. 20 Oct 23:40 SiliconANGLE Read the article →
29. 20 Oct 23:40 SiliconANGLE Read the article →

← Front page